Table 1.
Clinicopathological features of patients with salivary gland-type lung carcinoma
| Case number | Age | Size | Histologic type | Grade | LN1 | LN2 | Local recurrence | Metastasis |
|---|---|---|---|---|---|---|---|---|
| 1 | 21 | 4.5 | ACC | 3 | - | - | - | Liver |
| 2 | 36 | 5.5 | ACC | 2 | - | - | - | — |
| 3 | 46 | 5.1 | ACC | 1 | - | - | - | — |
| 4 | 47 | 2.8 | ACC | 2 | - | + | + | Brain/lung/bone |
| 5 | 48 | 3.3 | ACC | 2 | + | - | - | — |
| 6 | 51 | 4 | ACC | 2 | + | - | - | — |
| 7 | 57 | NA | ACC | 2 | - | + | + | Lung |
| 8 | 59 | 1.3 | ACC | 2 | - | + | - | Lung |
| 9 | 61 | >1.8 | ACC | 2 | - | + | + | — |
| 10 | 63 | NA | ACC | 2 | - | + | - | — |
| 11 | 66 | 1.8 | ACC | 3 | - | - | - | — |
| 12 | 76 | 2 | ACC | 2 | - | - | - | — |
| 13 | 18 | 2.4 | MEC | 1 | - | - | - | — |
| 14 | 21 | 2 | MEC | 2 | - | - | - | — |
| 15 | 24 | 2 | MEC | 1 | - | - | - | — |
| 16 | 28 | 2 | MEC | 1 | - | - | - | — |
| 17 | 36 | 1.2 | MEC | 1 | - | - | - | — |
| 18 | 40 | 1.5 | MEC | 2 | - | - | - | — |
| 19 | 40 | 1.8 | MEC | 1 | - | - | - | — |
| 20 | 41 | 1.6 | MEC | 2 | - | - | - | — |
| 21 | 47 | 3.5 | MEC | 2 | - | - | - | — |
| 22 | 61 | 3.3 | MEC | 2 | + | - | - | Bone |
| 23 | 63 | 4.5 | MEC | 2 | - | - | - | — |
| 24 | 65 | 0.9 | MEC | 2 | - | + | - | — |
ACC, adenoid cystic carcinoma; MEC, mucoepidermoid carcinoma; NA, not assessable; LN1, metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor lymph node metastasis; LN2, metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s).